Admission Date:  [**2174-8-11**]              Discharge Date:   [**2174-8-24**]  Date of Birth:  [**2135-11-15**]             Sex:   F  Service: MEDICINE  Allergies: Prochlorperazine / Heparin Agents  Attending:[**First Name3 (LF) 3565**] Chief Complaint: Fevers  Major Surgical or Invasive Procedure: Pericardiocentesis  History of Present Illness: Ms. [**Known firstname **] [**First Name4 (NamePattern1) 2431**] [**Known lastname **] is a 38yo F ALL s/p double cord blood SCT [**1-/2173**] c/b GVHD, severe left ventricular systolic dysfunction attributed to chemotherapy for ALL as well as XRT for [**Year (4 digits) 3242**] (EF 15-20%), embolic CVA now on coumadin, asthma, hypertension and chronic kidney disease, well-known to the [**Year (4 digits) 3242**] service who was just discharged yesterday ([**2174-8-10**]) after a prolonged hospital course for acute on chronic CHF thought be be due to cardiac GVHD and acute on chronic renal failure.
She was discharged home with daily infusions of IV torsamide and methylprednisolone.
Blood (PICC and peripheral) and urine cultures were sent, and she was started on empiric meropenem.
Per her sister, the pt got her torsemide and methyprednisolone in clinic today.
- underwent phase I induction with daunorubicin, vincristine, dexamethasone, L-asparaginase, MTX; phase II with cyclophosphamide, cytarabine, mercaptopurine, MTX - Bone Marrow Aspirate/Biopsy on [**2172-10-26**] showed no morphologic evidence of residual leukemia - underwent allo double cord blood SCT [**2173-1-11**], course complicated by neutropenic fever and acute skin GVHD - subsequent course has been complicated by pseudomonas pneumonia in [**5-15**], empiric treatment of CMV pericarditis in [**7-15**], chronic nausea and vomiting which has been treated as GVHD with steroids though colonoscopies in [**8-14**] and [**11-14**] were negative for GVHD.
OTHER MEDICAL HISTORY: - Embolic stroke in [**3-/2174**] on coumadin - Asthma - Hypertension - Cervical Intraepithelial Neoplasia - C-section in [**2165**] - Cardiomyopathy due to early anthracycline-related cardiotoxicity [**10/2172**] - Chronic kidney disease stage III/IV, baseline creatinine ~2.0 - Chronic abdominal pain: Her workup so far has included EGD [**2173-9-5**], [**2173-11-5**] with mild signs of gastritis, no GVHD.
Progression of bilateral pulmonary infiltrates in this patient on stem cell transplant therapy.
The epicardial surface of the right ventricle as well as atria appears to be encased in a layer of echodense material (epicardial fat vs consolidated effusive material).
Moderate-sized bilateral pleural effusions and a small amount of ascites   Brief Hospital Course: 38 year old female with ALL s/p cord blood transplant complicated by multi-organ GVHD admitted directly to the ICU for recurrent fever and increased pulmonary infiltrates on CXR.
She received a dose of meropenem, blood and urine cultures were sent, and she was admitted directly to the ICU.
After transfer to the ICU she was given IV fluids and continued on broad-spectrum antibiotics (vancomycin, cefepime), antifungal (voriconazole) and antiviral (gancyclovir).
Bronchoscopy lavage fluid was sent for pan-culture, pneumocystis smear, and CMV screen.
CMV pneumonitis was suspected given previous BAL CMV+.
Hypoxia and work of breathing worsening and she required intubation for ventilation (see below).
She received vancomycin, cefepime, ganciclovir, voriconazole, and amphotericin B for broad anti-bacterial, anti-fungal, and anti-viral coverage.
She was sedated on fentanyl and versed due to agitation and discomfort on the vent.
She required mechanical ventilation at an Fi02 of 100% O2 until the time of expiration.
#Congestive heart failure with systolic dysfunction: Patient has known CHF with systolic dysfunction from chemo, XRT and suspected cardiac GVHD.
NiCOM maneuvers were performed and a transesophageal Balloon was placed for pleural pressure monitoring.
CVVHD was discontinued as the patient developed hypotension despite being on three pressors.
#ALL: Pt is s/p double cord blood SCT [**1-/2173**] complicated by GVHD on immunosuppression, recently discharged on mycophenolate, IV solumedrol and bactrim/acyclovir for prophylaxis.
Her mycophenolate dose was changed to 500 mg PO BID and she was continued on this plus 60 mg IV solumedrol daily.
She was on Bactrim prophylaxis prior to admission, and this was increased to therapeutic dosing while in the ICU.
Home nifedipine and lopressor were held.
Medications on Admission: -acyclovir 400 mg Tablet One (1) Tablet by mouth every twelve (12) hours.
-albuterol sulfate 2.5 mg /3 mL (0.083 %) Solution for Nebulization One (1) Neb Inhalation every six (6) hours as needed for SOB, wheezing -digoxin 125 mcg Tablet One (1) Tablet by mouth EVERY OTHER DAY.
-ergocalciferol (vitamin D2)50,000 unit Capsule One (1) Capsule by mouth 1X/week -lorazepam 0.5 mg Tablet One (1) Tablet by mouth every six (6) hours as needed for anxiety/nausea.
-methylprednisolone sodium succ Sixty (60) mg Intravenous once a day.
-metoprolol succinate 50 mg Tablet Extended Release 24 hr, One (1) Tablet Extended Release 24 hr by mouth once a day -morphine [MS Contin]15 mg Tablet Extended Release One (1) Tablet Extended Release by mouth twice a day.
-mycophenolate mofetil 500 mg Tablet Two (2) Tablet by mouth twice a day.
-nifedipine 60 mg Tablet Extended Release One (1) Tablet Extended Release by mouth once a day in the evening.
-NPH insulin human recomb Ten (10) units Subcutaneous twice a day: Please administer 10 units before breakfast and 10 units before dinner.
-omeprazole 40 mg Capsule, Delayed Release(E.C.)
-ondansetron 4 mg Tablet, Rapid Dissolve [**2-6**] Tablet, Rapid Dissolves by mouth three times a day as needed for nausea.
-oxycodone 5 mg Tablet One (1) Tablet by mouth every 4-6 hours as needed for pain.
-sildenafil 20 mg Tablet Four (4) Tablet by mouth three times a day.
-sulfamethoxazole-trimethoprim 400-80 mg Tablet One (1) Tablet by mouth DAILY (Daily).
-torsemide 20 mg/2 mL (10 mg/mL) Solution Forty (40) mg Intravenous once a day.
-voriconazole 200 mg Tablet One (1) Tablet by mouth every twelve (12) hours.
